Express News | Vir Biotechnology Inc : JP Morgan Raises Target Price to $12 From $10
Reuters19minutes ago
Why Moderna Stock Blasted 13% Higher Today
Yahoo Finance18:36 ET
Amgen Stock Rallies 13% on Weight-loss Drug Updates, Tweaked Guidanace
Seeking Alpha17:40 ET
Moderna's Sales From Its Only Product, the COVID-19 Vaccine, Fell 91% From Last Year
Yahoo Finance17:21 ET
Express News | Vir Biotechnology Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results
Benzinga17:19 ET
Moderna Options Spot-On: On May 2nd, 132.6K Contracts Were Traded, With 296.75K Open Interest
On May 2nd ET, $Moderna(MRNA.US)$ had active options trading, with a total trading volume of 132.6K options for the day, of which put options accounted for 34.77% of the total transactions, and call o
moomoo News16:30 ET
Pfizer Options Spot-On: On May 2nd, 345.72K Contracts Were Traded, With 3.32 Million Open Interest
On May 2nd ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 345.72K options for the day, of which put options accounted for 46.28% of the total transactions, and call op
moomoo News16:30 ET
Express News | Vir Biotechnology - Effective May 3 Sung Lee, Executive Vice President and Chief Financial Officer Will Be Stepping Down
Reuters16:29 ET
Express News | Vir Biotechnology Inc - $1.51 Bln in Cash, Cash Equivalents and Investments as of March 31, 2024
Reuters16:28 ET
Express News | Vir Biotechnology Reiterates FY24 GAAP Combined R&D And SG&A Expense Range $650M-$680M
Benzinga16:22 ET
Novo Nordisk Slides While Moderna Pops: Tale of Two Pharma Stocks
Yahoo Finance16:17 ET
Research Alert: CFRA Retains Hold Opinion On Shares Of Moderna, Inc.
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We up our target price to $115 from $88
MT Newswires16:15 ET
Earnings Flash (VIR) VIR BIOTECHNOLOGY Reports Q1 Revenue $56.4M, Vs. Street Est of $11.7M
04:11 PM EDT, 05/02/2024 (MT Newswires) -- Earnings Flash (VIR) VIR BIOTECHNOLOGY Reports Q1 Revenue $56.4M, vs. Street Est of $11.7M
MT Newswires16:11 ET
Analysts Conflicted on These Healthcare Names: InMode (INMD) and Pfizer (PFE)
TipRanks16:10 ET
Express News | Vir Biotechnology Q1 2024 GAAP EPS $(0.48) Beats $(1.07) Estimate, Sales $56.400M Beat $11.712M Estimate
Benzinga16:10 ET
Market Chatter: Novo Nordisk, Eli Lilly's Weight-Loss Drugs Get Price Cuts in UK
Novo Nordisk's (NVO) Wegovy and Eli Lilly's (LLY) Mounjaro had their prices lowered by British online pharmacies and slimming clinics as supply shortages ease after the drugs' recent launch, Reuters r
MT Newswires16:08 ET
Press Release: Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results -- Late-breaker SOLSTICE data abstract accepted for poster presentation at the European Association for th
Dow Jones16:05 ET
Express News | Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
Reuters16:05 ET
Express News | Vir Biotechnology Q1 Cash & Investments USD 1,510 Million
Reuters16:05 ET
Vir Biotechnology 1Q Rev $56.4M >VIR
Vir Biotechnology 1Q Rev $56.4M >VIR
Dow Jones16:05 ET